Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Liquid Molecular Testing Panel in the Community Setting ("DINOSAur II")
Launched by GLENDALE ADVENTIST MEDICAL CENTER D/B/A ADVENTIST HEALTH GLENDALE · Jan 25, 2023
Trial Information
Current as of June 05, 2025
Unknown status
Keywords
ClinConnect Summary
The DINOSAur II clinical trial is researching new treatment options for patients with advanced solid tumors (Stage III and IV cancer). The goal is to find out if a special blood test, called a liquid molecular test, can identify specific markers in tumors. These markers can help doctors choose the most effective treatment for each patient. The study is currently looking for participants who have not yet started treatment for their cancer and are at least 18 years old. Patients will need to provide consent and be willing to share their medical records with the research team.
If you join this trial, you can expect to have a blood sample taken as part of your regular care. The results of the liquid molecular test will help guide your treatment options, which could lead to a more personalized approach to your cancer care. It’s important to note that only certain patients can participate, specifically those who are not minors, prisoners, or unable to provide consent. This trial aims to improve how we treat cancer patients in the community setting by identifying targeted therapies that may work best for them.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who have given informed consent in accordance with the methods and procedures of this study
- • Diagnosis of cancer (stage 3 and stage 4; solid tumors only) requiring medical care
- • Patients who have not received treatment related to his/her cancer
- • Patients who are willing to sign a release of medical records to the research team
- • Male and female patients ≥18 years of age
- • Patients under oncology care
- • Sufficient clinical status for collection of blood sample within usual care
- Exclusion Criteria:
- • Patients considered minors in the jurisdiction where the protocol is conducted
- • Patients who are prisoners and pregnant women
- • Patients who cannot provide consent and did not sign a power of attorney
About Glendale Adventist Medical Center D/B/A Adventist Health Glendale
Glendale Adventist Medical Center, operating as Adventist Health Glendale, is a leading healthcare institution dedicated to providing high-quality medical services and advancing clinical research. With a commitment to holistic patient care and community wellness, the center integrates innovative practices and evidence-based approaches to enhance health outcomes. As a sponsor of clinical trials, Adventist Health Glendale aims to contribute to medical advancements while ensuring the safety and well-being of participants. The center's collaborative environment and experienced research team enable the exploration of new therapies and treatments, reinforcing its mission to improve lives through compassionate care and scientific discovery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Glendale, California, United States
Patients applied
Trial Officials
Mihran H Shirinian, MD
Principal Investigator
Glendale Adventist Medical Center dba Adventist Health Glendale
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials